Literature DB >> 24374219

A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.

Xiaohong Liu1, Shang Wang1, Liqing Chai2, Dong Zhang1, Yinghua Sun1, Lu Xu3, Jin Sun4.   

Abstract

In order to decrease the fluctuation of blood concentration and to increase the oral bioavailability of nimodipine (NMD), a two-step strategy including the push-pull osmotic pump (PPOP) method in combination with micronization and solid dispersion techniques, was used to prepare the controlled-release high-bioavailability solid dosages. The optimization of formulation and process was conducted by comparing effects of different solubilization methods on release behavior of NMD. The in vitro dissolution studies indicated that both the two strategies were able to deliver NMD in the predetermined zero-order manner from 2 to 12h, regardless of effects of release media and agitation rates. Although the Cmax values of two PPOP tablets were lower than that of the reference formulation, both the Tmax values were prolonged, demonstrating the prominent controlled release performance. In comparison with the commercial reference tables, the relative bioavailability of the two formulations was 67.0% and 121.1%, respectively, indicating the solid dispersion technique was more efficient than the micronization technique in terms of solubilization capability and absorption enhancement. In summary, the two-step strategy, combining the push-pull osmotic pump method with the solid dispersion technique, is a very effective method to prepare high bioavailable controlled-release formulations of the poorly soluble drugs, i.e. NMD, taking into account the therapeutical efficiency and safety.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  A two-step strategy; Bioavailability; Micronization; Nimodipine; Push–pull osmotic pump; Solid dispersion

Mesh:

Substances:

Year:  2013        PMID: 24374219     DOI: 10.1016/j.ijpharm.2013.12.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Nimodipine Ophthalmic Formulations for Management of Glaucoma.

Authors:  Doaa Nabih Maria; Abd-Elgawad Helmy Abd-Elgawad; Osama Abd-Elazeem Soliman; Marwa Salah El-Dahan; Monica M Jablonski
Journal:  Pharm Res       Date:  2017-02-02       Impact factor: 4.200

2.  Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.

Authors:  Dongyang Fang; Yining Yang; Mengsuo Cui; Hao Pan; Lijie Wang; Pingfei Li; Wenjing Wu; Sen Qiao; Weisan Pan
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

3.  Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.

Authors:  Zongzhe Zhao; Chao Wu; Ying Zhao; Yanna Hao; Ying Liu; Wenming Zhao
Journal:  Int J Nanomedicine       Date:  2015-03-03

Review 4.  Advances in drug delivery systems: Work in progress still needed?

Authors:  Flavia Laffleur; Valérie Keckeis
Journal:  Int J Pharm X       Date:  2020-06-12

5.  Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability.

Authors:  Zaijin Teng; Miao Yu; Yang Ding; Huaqing Zhang; Yan Shen; Menglao Jiang; Peixin Liu; Yaw Opoku-Damoah; Thomas J Webster; Jianping Zhou
Journal:  Int J Nanomedicine       Date:  2018-12-21

6.  Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation.

Authors:  Yuenan Li; Hao Pan; Hongliang Duan; Jianting Chen; Zhihong Zhu; Jingxin Fan; Pingfei Li; Xinggang Yang; Weisan Pan
Journal:  Asian J Pharm Sci       Date:  2018-08-19       Impact factor: 6.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.